Sökning: onr:"swepub:oai:DiVA.org:uu-410275" >
Adenosine usage dur...
Adenosine usage during AF ablation in Europe and selected long-term findings from the ESC-EHRA EORP Atrial Fibrillation Ablation Long-Term registry.
-
van Rosmalen, Frank (författare)
-
Delhaas, Tammo (författare)
-
Dagres, Nikolaos (författare)
-
visa fler...
-
Arbelo, Elena (författare)
-
- Blomström-Lundqvist, Carina (författare)
- Uppsala universitet,Kardiologi-arrytmi,Kardiologi
-
Crijns, Harry J G M (författare)
-
Da Costa, Antoine (författare)
-
Pytkowski, Mariusz (författare)
-
Sharikov, Nikita (författare)
-
Laroche, Cécile (författare)
-
Tavazzi, Luigi (författare)
-
Brugada, Joseph (författare)
-
Pison, Laurent (författare)
-
visa färre...
-
(creator_code:org_t)
- 2020-04-30
- 2021
- Engelska.
-
Ingår i: Journal of Interventional Cardiac Electrophysiology. - : Springer Science and Business Media LLC. - 1383-875X .- 1572-8595. ; 60, s. 395-406
- Relaterad länk:
-
https://link.springe...
-
visa fler...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- BACKGROUND: Adenosine can be used to reveal dormant pulmonary vein (PV) conduction after PV isolation (PVI). This study presents a subanalysis of real-world 1-year follow-up data from the ESC-EHRA EORP Atrial Fibrillation (AF) Ablation Long-Term registry to analyze the usage of adenosine during PVI treatment in terms of rhythm outcome and safety.METHODS: The registry consists of 104 participating centers in 27 countries within the European Society of Cardiology. The registry data was split into an adenosine group (AG) and no-adenosine group (NAG). Procedure characteristics and patient outcome were compared.RESULTS: Adenosine was administered in 10.8% of the 3591 PVI patients included in the registry. Spain, the Netherlands, and Italy included the majority of adenosine cases (48.8%). Adenosine was applied more often in combination with open irrigation radiofrequency (RF) energy (74.7%) and less often in combination with nonirrigated RF energy (1.6%). After 1 year, a higher percentage of the AG was free from AF compared with the NAG (68.9% vs 59.1%, p < 0.001). Adenosine was associated with better rhythm outcome in RF ablation procedures, but not in cryo-ablation procedures (freedom from AF: RF: AG: 70.9%, NAG: 58.1%, p < 0.001, cryo: AG: 63.9%, NAG: 63.8%, p = 0.991).CONCLUSIONS: The use of adenosine was associated with a better rhythm outcome after 1 year follow-up and seems more useful in patients treated with RF energy compared with patients treated with cryo energy. Given the improved rhythm outcome at 1-year follow-up, it seems reasonable to encourage the use of adenosine during RF AF ablation.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Nyckelord
- Adenosine
- Follow-up
- Pulmonary vein isolation
- Rhythm outcome
- Safety
- Cardiology
- Kardiologi
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
van Rosmalen, Fr ...
-
Delhaas, Tammo
-
Dagres, Nikolaos
-
Arbelo, Elena
-
Blomström-Lundqv ...
-
Crijns, Harry J ...
-
visa fler...
-
Da Costa, Antoin ...
-
Pytkowski, Mariu ...
-
Sharikov, Nikita
-
Laroche, Cécile
-
Tavazzi, Luigi
-
Brugada, Joseph
-
Pison, Laurent
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
- Artiklar i publikationen
-
Journal of Inter ...
- Av lärosätet
-
Uppsala universitet